HCP stock: buy or sell?

HCP stock price: $33.69 0.15% At close on November 8th, 2019

Updated on:
November 8th, 2019

2

HCP remained stable a tight 0.15% and closed at $33.69.

HCP, Inc. is a fully integrated real estate investment trust (REIT) that invests primarily in real estate serving the healthcare industry in the United States.

Should I buy HCP stock?

You can't be a successful trader if you don't follow a methodolgy or system that assist you in choosing companies and the correct market timing. Trading strategies are meant for helping you in the decision process of what stocks to pick and when is the best time to buy them. There are thousands of trading strategies for you to choose, but at Stocks2.com we prefer those that are simple but successful.

Currently, HCP stock doesn't match any of these trading strategies, so our recommendation is not to buy.

Buy setupElegible
New all-time highNo
New 52 week highNo
Price crossing up 200d MANo
100d MA crossing up 200d MANo
This is not a selling recommendation at all, just it's not the best moment to buy if you follow any of these trading strategies.

Is HCP stock a buy?

Financial institutions and banks post stock ratings everyday. At Stocks2.com, we collected 8 ratings published for HCP stock in the last month.

The general sentiment of these ratings is bullish for HCP stock, with 6 positive ratings.
Is HCP a good stock to buy?
DateAnalyst / BrokerPrevious ratingCurrent rating
2019-9-3Stifel Nicolausn/aBuy
2019-9-3Barclaysn/aOverweight
2019-9-17Morgan Stanleyn/aEqual Weight
2019-9-10JPMorgan Chase & Co.n/aNeutral
2019-9-10ArgusHoldBuy
2019-8-1Stifel Nicolausn/aBuy
2019-7-1KeyCorpn/aOverweight
2019-6-13Raymond JamesMarket PerformOutperform

HCP stock analysis

Daily outlook

HCP remained stable a tight 0.15% and closed at $33.69.

HCP remained stable a tight 0.15% and closed at $33.69. On October, HCP hit new all time highs, pushing higher previous ATH of $37.56 recorded on October. New ATHs are usual entry points for many trading setups as there aren't higher resistences.

HCP stock chart (daily)

Weekly outlook

HCP shares collapsed -8.23% early November, ending at $33.69.

HCP stock is drawing an uptrend with rising tops and bottoms. Now trading in between its last bottom and last top, HCP might consolidate in a flat-base, waiting to break out over or down under . Not so far away is the last price record HCP marked late October 2019. Early November, HCP stock lost the significant level of the 20-weeks moving average.

HCP stock chart (weekly)

HCP stock price history

HCP IPO was on May 23rd, 1985 at $0.00 per share1. Since then, HCP stock grew a inf%, with an average of inf% per year. If you had invested $1,000 in HCP stock in 1985, it would worth $inf today.

1: Adjusted price after possible price splits or reverse-splits.

HCP stock historical price chart

HCP stock reached all-time highs on October with a price of $37.56.

HCP stock price target is $35.30

Predicting the price evolution of a stock or any financial instrument in a reliable and repeatable way is probably impossible. However, financial institutions invest time and resources to provide the most accurated estimations to help investors to make their decisions. The accuracy of these stock price predictions is not very high, and you should not blindly believe and make decisions only based on what this ratings or price target predictions say. We detected 7 price forecasts for HCP stock published in the last month:
HCP stock price predictions
DateAnalyst / BrokerActionPrevious targetCurrent targetDiff
2019-9-3Stifel NicolausReiterates$34.00$37.008.8%
2019-9-3BarclaysInitiatesn/a$37.00-
2019-9-17Morgan StanleyRaises Target$32.00$35.009.4%
2019-9-10JPMorgan Chase & Co.Raises Target$32.00$35.009.4%
2019-8-1Stifel NicolausRaises Target$32.00$34.006.3%
2019-7-1KeyCorpRaises Target$32.00$34.006.3%
2019-6-13Raymond JamesUpgradesn/a$35.00-
(in average)$32.40$35.309.0%
Moving in a range from $37.00 and $34.00, the price prediction for HCP stock is $35.30. In average, analysts' outlook on HCP price forecast is positive, increasing the forecast by a 9.00% from previous estimations.

Financials and fundamental analysis

Earnings date and Earnings per Share

On February, HCP presented its financial report, aligned with analysts' consensus and published a $0.43 Earnings per Share. As soon as we get its posted EPS from the earnings report, we will extend this review.
HCP earnings date and EPS evolution
QuarterReporting dateEstimated EPSActual EPSSurprise
2017-Q2-n/a0.66n/a
2017-Q32017-11-020.15-0.02n/a
2017-Q42018-02-130.17-0.09n/a
2018-Q12018-05-030.460.484.3%
2018-Q22018-08-020.460.472.2%
2018-Q32018-10-310.430.442.3%
2018-Q42019-02-130.430.430.0%
2019-Q1-n/an/an/a
2019-Q2-n/an/an/a
2019-Q3-n/an/an/a

Annual financial results

In 2018, HCP annual turnover stepped up a slightly good 2.54% to $1,782.01 M dollars from $1,737.92 marked in 2017. When comparing 2018 vs 2017, on the other hand, profit margin (that is, the net income divided by revenues) climbed a 35.71% to 59.54%.

HCP annual Sales and Income evolution
YearSalesYoYIncome/(margin)YoY
2013$2,110 M-$895 M42.4%-
2014$1,529 M-27.55%$922 M60.3%3.07%
2015$1,798 M17.63%$-559.24 M-31.1%-160.64%
2016$1,981 M10.16%$628 M31.7%-212.25%
2017$1,738 M-12.27%$414 M23.8%-34.02%
2018$1,782 M2.54%$1,061 M59.5%156.20%

Quarterly financial results

HCP reported $426.62 M in revenues for 2018-Q4, a -3.31% less compared to previous quarter. Reported quarter earnings marked $831.55 M with a profit margin of 194.92%. Profit margin boosted a 172.39% compared to previous quarter when profit margin was 22.52%. When comparing turnover to same quarter last year, HCP sales marked a tight movement and stayed constant a 0.55%. Looking back to recent quarterly results, HCP posted 3 negative quarters in a row.
HCP quarterly Sales and Income evolution
QuarterSales1QoQ2Income1/(margin)QoQ2
2017-Q2$459 M-$19 M4.2%-
2017-Q3$429 M-6.52%$-8 M-1.8%-139.71%
2017-Q4$424 M-1.10%$-59 M-13.8%666.64%
2018-Q1$460 M8.31%$40 M8.8%-168.54%
2018-Q2$455 M-1.08%$90 M19.8%123.56%
2018-Q3$441 M-2.95%$99 M22.5%10.48%
2018-Q4$427 M-3.31%$832 M194.9%736.81%
2019-Q1$421 M-1.34%$61 M14.6%-92.61%

HCP ownership

When you are planning to invest in shares of a company, it's always worth to overview its ownership structure.

Management staff in all public traded companies that hold equity is required to report every transaction to the SEC. For HCP, of all outstanding shares are owned by its staff.

Bearish positions for HCP stock account 0.00%, no big difference from last month.

The following table compares ownership indicators for other stocks related to HCP:

HCP
Market cap$16.5 B
Total shares491.1 M
Float shares493.7 M
  - Institutional holdings (%)0.0%
  - Insider holdings (%)0.0%
Shares in short selling0.0%

HCP summary

Friday, November 8th, 2019
Open$33.59
Close$33.69
Day range$33.38 - $33.83
Previous close$33.64
Session gain0.15%
Average true range$0.95
50d mov avg$35.49
100d mov avg$33.98
200d mov avg$32.00
Daily pattern
Weekly pattern lt06a

HCP performance

To better understand HCP performance you must becnhmark its gains with other related stocks in same sector or industry. In the following table, we compare HCP to :
Stock3m6m12m
HCP -0.21%13.47%22.33%

HCP competitors

Unfortunately, we could not find any public company that could be defined as HCP competitor. This doesn't mean HCP does not have any competitor in the market, it's just we could not detected it.